Repeat Screening for Syphilis in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the cost-effectiveness of screening all women during the first and third trimesters compared with screening just once during pregnancy. METHODS: We used a theoretical cohort of 3.9 million women in the United States to model syphilis screening approaches in pregnancy, particularly comparing one-time screening with repeat third-trimester screening. Outcomes of syphilis infection included in the model were congenital syphilis, intrauterine fetal demise, neonatal death, and total quality-adjusted life-years (QALYs). Probabilities, utilities, and costs were obtained from the literature, and a cost-effectiveness threshold was set at $100,000 per QALY. A societal perspective was assumed. RESULTS: Our model demonstrated that repeat screening in the third trimester for syphilis in pregnancy will result in fewer maternal and neonatal adverse outcomes and higher QALYs when compared with screening once in the first trimester. Specifically, we demonstrated that repeat screening results in 41 fewer neonates with evidence of congenital syphilis, 73 fewer cases of intrauterine fetal demise, 27 fewer neonatal and infant deaths, in addition to a cost savings of $52 million and 4,000 additional QALYs. CONCLUSION: Using our baseline assumptions, our data support that in pregnancy, repeat screening for syphilis is superior to single screening during the first trimester and is both cost-effective and results in improvement in maternal and neonatal outcomes. When screening policies are being created for pregnant women, the cost-effectiveness of repeat screening for syphilis should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis
Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.107623 · Cited by 634
Comprehensive cost-utility analysis of newborn screening strategies
Carroll, A. E., & Downs, S. M. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2633h · Cited by 165
Qin, J., Yang, T., Xiao, S., Tan, H., Feng, T., & Fu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102203 · Cited by 132
Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis
Albright, C. M., Emerson, J. B., Werner, E. F., & Hughes, B. L. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000997 · Cited by 31
Cited by
Trinh, T., Leal, A. F., Mello, M. B., Taylor, M. M., Barrow, R., Wi, T. E., & Kamb, M. L. (2019) · Sexual and Reproductive Health Matters · doi:10.1080/26410397.2019.1691897 · Cited by 46
Congenital Syphilis: A Re-Emerging but Preventable Infection
Salomè, S., Cambriglia, M. D., Montesano, G., Capasso, L., & Raimondi, F. (2024) · Pathogens · doi:10.3390/pathogens13060481 · Cited by 44
“…recent evidence demonstrated that nearly half of patients did not report any risk factors [47] and repeating the screening for syphilis is superior to a single screening during the first trimester in terms of cost effectiveness and results in an improvement in maternal and neonatal outcomes [48].”
BackgroundTsai, S., Sun, M. Y., Kuller, J. A., Rhee, E. H. J., & Dotters-Katz, S. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000713 · Cited by 36
“can be cost-effective follows from the relative inexpensiveness of screening and treatment compared with the very high costs of adverse outcomes.(36)”
ResultGilmour, L. S., Best, E. J., Duncanson, M. J., Wheeler, B. J., Sherwood, J., Thirkell, C. E., & Walls, T. (2022) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003233 · Cited by 16
“In addition, a recent United States based cost-effectiveness analysis study found that repeat syphilis screening in the third trimester would result in fewer maternal and neonatal adverse outcomes, and higher total quality-adjusted lifeyears when compared with screening once in the first trimester.(28) A strength of t…”
BackgroundGratrix, J., Karwacki, J., Eagle, L., Rathjen, L., Singh, A., Chu, A., & Smyczek, P. (2022) · Canada Communicable Disease Report · doi:10.14745/ccdr.v48i23a02 · Cited by 13
Metadata
- Authors
- Hersh, A. R., Megli, C. J., & Caughey, A. B.
- Venue
- Obstetrics & Gynecology
- Published
- 2018-09
- Volume
- 132
- Issue
- 3
- Pages
- 699-707
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2887145204
- Cited by
- 46
- References
- 4
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repeat Screening for Syphilis in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis. https://app.cochat.ai/papers/10.1097/aog.0000000000002795
- The paper
- Hersh, A. R., Megli, C. J., & Caughey, A. B. (2018). Repeat Screening for Syphilis in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000002795
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.